Filing Details

Accession Number:
0001209191-15-024337
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-09 20:58:31
Reporting Period:
2015-03-05
Filing Date:
2015-03-09
Accepted Time:
2015-03-09 20:58:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1305253 Celladon Corp CLDN Biological Products, (No Disgnostic Substances) (2836) 330971591
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1484780 Peter Honig 11988 El Camino Real, Suite 650
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-05 2,500 $11.30 2,500 No 4 M Direct
Common Stock Acquisiton 2015-03-05 2,200 $11.30 4,700 No 4 M Direct
Common Stock Disposition 2015-03-05 2,500 $22.50 2,200 No 4 S Direct
Common Stock Disposition 2015-03-05 2,200 $22.29 0 No 4 S Direct
Common Stock Acquisiton 2015-03-06 5,000 $9.58 5,000 No 4 M Direct
Common Stock Disposition 2015-03-06 5,000 $25.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2015-03-05 2,500 $0.00 2,500 $11.30
Common Stock Stock option (right to buy) Disposition 2015-03-05 2,200 $0.00 2,200 $11.30
Common Stock Stock option (right to buy) Disposition 2015-03-06 5,000 $0.00 5,000 $9.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2014-04-02 2024-03-01 No 4 M Direct
17,800 2014-04-02 2024-03-01 No 4 M Direct
12,800 2014-06-20 2024-05-19 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 12, 2014.
  2. All shares subject to the option have vested and are exercisable as of the date of this filing.
  3. 1/36th of the Option vests each month after March 2, 2014 (the "Vesting Commencement Date") such that the Option will be fully vested three years after March 2, 2014.
  4. 1/12th of the Option vests each month after May 20, 2014 (the "Vesting Commencement Date") such that the Option will be fully vested one year after May 20, 2014.